BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20161858)

  • 1. Mucocutaneous changes in tuberous sclerosis complex: a clinical profile of 27 Indian patients.
    Ghosh SK; Bandyopadhyay D; Chatterjee G; Ghosh A; Sarkar S; Sarkar S
    Indian J Dermatol; 2009 Jul; 54(3):255-7. PubMed ID: 20161858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological Patterns of Skin Lesions in Tuberous Sclerosis Complex: A Panorama.
    Cascarino M; Leclerc-Mercier S
    Dermatopathology (Basel); 2021 Jul; 8(3):236-252. PubMed ID: 34287284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance.
    Jóźwiak S; Schwartz RA; Janniger CK; Michałowicz R; Chmielik J
    Int J Dermatol; 1998 Dec; 37(12):911-7. PubMed ID: 9888331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches.
    Bongiorno MA; Nathan N; Oyerinde O; Wang JA; Lee CR; Brown GT; Moss J; Darling TN
    JAMA Dermatol; 2017 Jul; 153(7):660-665. PubMed ID: 28445558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and radiological findings related to tuberous sclerosis complex: a case report.
    Gupta S; Bhowate R; Degwekar SS
    J Contemp Dent Pract; 2008 May; 9(4):85-91. PubMed ID: 18473031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrous cephalic plaques in tuberous sclerosis complex.
    Oyerinde O; Buccine D; Treichel A; Hong C; Lee CR; Moss J; Darling TN
    J Am Acad Dermatol; 2018 Apr; 78(4):717-724. PubMed ID: 29258863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of tuberous sclerosis cases.
    Söğüt A; Ozmen M; Sencer S; Calişkan M; Aydinli N; Ertuğrul T; Peksayar G
    Turk J Pediatr; 2002; 44(2):98-101. PubMed ID: 12026215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
    Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
    Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A different approach for identifying hypomelanotic macules in tuberous sclerosis complex.
    Gualandri L; Boccardi D; Menni S
    G Ital Dermatol Venereol; 2015 Oct; 150(5):501-3. PubMed ID: 26333551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients.
    Malissen N; Vergely L; Simon M; Roubertie A; Malinge MC; Bessis D
    J Am Acad Dermatol; 2017 Sep; 77(3):464-472.e3. PubMed ID: 28502378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous Sclerosis.
    Amorim BDB; Azulay D; Ramos-E-Silva M
    Skinmed; 2021; 19(3):179-185. PubMed ID: 34303387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Para clinical Manifestations of Tuberous Sclerosis: A Cross Sectional Study on 81 Pediatric Patients.
    Tonekaboni SH; Tonekaboni SH; Tousi P; Ebrahimi A; Ahmadabadi F; Keyhanidoust Z; Zamani G; Rezvani M; Amirsalari S; Tavassoli A; Rounagh A; Rezayi A
    Iran J Child Neurol; 2012; 6(3):25-31. PubMed ID: 24665269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.
    Wataya-Kaneda M; Tanaka M; Yang L; Yang F; Tsuruta D; Nakamura A; Matsumoto S; Hamasaki T; Tanemura A; Katayama I
    JAMA Dermatol; 2015 Jul; 151(7):722-30. PubMed ID: 25692384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous Sclerosis Complex: Clinical Spectrum and Epilepsy: A Retrospective Chart Review Study.
    Almobarak S; Almuhaizea M; Abukhaled M; Alyamani S; Dabbagh O; Chedrawi A; Khan S; Aldhalaan H
    Transl Neurosci; 2018; 9():154-160. PubMed ID: 30479846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.
    Wienecke R; Klemm E; Karparti S; Swanson NA; Green AJ; DeClue JE
    J Cutan Pathol; 2002 May; 29(5):287-90. PubMed ID: 12100629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forehead plaque: a cutaneous marker of CNS involvement in tuberous sclerosis.
    Rama Rao GR; Krishna Rao PV; Gopal KV; Kumar YH; Ramachandra BV
    Indian J Dermatol Venereol Leprol; 2008; 74(1):28-31. PubMed ID: 18187819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of epilepsy in tuberous sclerosis.
    Anisya-Vasanth AV; Satishchandra P; Nagaraja D; Swamy HS; Jayakumar PN
    Neurol India; 2004 Jun; 52(2):210-2. PubMed ID: 15269473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognizing an index case of tuberous sclerosis.
    Hurst JS; Wilcoski S
    Am Fam Physician; 2000 Feb; 61(3):703-8, 710. PubMed ID: 10695583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from eastern India.
    Ghosh SK; Bandyopadhyay D; Saha I; Barua JK
    Indian J Dermatol; 2012 May; 57(3):201-5. PubMed ID: 22707772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis complex.
    Islam MP; Roach ES
    Handb Clin Neurol; 2015; 132():97-109. PubMed ID: 26564073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.